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Abstract
Purpose: To assess and quantify by molecular imaging knee osseous metabolic changes serially in an in vivo canine model of
posttraumatic osteoarthritis (PTOA) of the knee utilizing sodium fluoride (Na18F) positron emission tomography (PET)/com-
puted tomography (CT) coregistered with magnetic resonance imaging (MRI).
Materials and Methods: Sodium fluoride PET imaging of 5 canines was performed prior to anterior cruciate ligament trans-
ection (ACLT) and 2 times post-ACLT (3 and 12 weeks). The PET/CT was coregistered with MRI, enabling serial anatomically
guided visual and quantitative three-dimensional (3D) region of interest (ROI) assessment by maximum standardized uptake value.
Results: Prior to ACLT, every 3D ROI assessed in both knees showed no Na18F uptake above background. The uptake of Na18F
in the bone of the ACLT knees increased exponentially, presenting significantly higher uptake at 12 weeks in every region
compared to the ACLT knees at baseline. Furthermore, the uninjured contralateral limb and the ipsilateral distal bones and joints
presented Na18F uptake at 3 and 12 weeks post-ACLT.
Conclusion: This study demonstrated that Na18F PET/CT coregistered with MRI is a feasible molecular imaging biomarker to
assess knee osseous metabolic changes serially in an in vivo canine model of knee PTOA. Moreover, it brings a novel muscu-
loskeletal preclinical imaging methodology that can provide unique insights into PTOA pathophysiology.
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Introduction
Osteoarthritis (OA) is a leading cause of disability world-
wide with age, obesity, and trauma or injury, representing
major risk factors for disease development and progression.1
One of the most common musculoskeletal traumatic injuries
is disruption of the anterior cruciate ligament (ACL).2
Young women performing pivoting sports, such as soccer
and basketball, have a significantly higher risk of ACL
injury than men.3 Most patients with acute ACL tears are
younger than 30 years of age at the time of their injury. As
such, ACL injuries resulting in early-onset OA were asso-
ciated with pain, functional limitations, and decreased
quality of life. Reported incidence of posttraumatic osteo-
arthritis (PTOA) following ACL injury is as high as 87%.3
Individuals with ACL tears have a higher incidence of
PTOA, approximately 50% between 10 and 20 years post-
injury.4 The increasing importance of comprehensive
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noninvasive imaging of OA for diagnosis, prognosis, and
follow-up is well recognized.
Although conventional radiography is the gold standard
imaging technique for the evaluation of OA in clinical practice
and in clinical trials, more sensitive imaging modalities are
needed for the earlier diagnosis of PTOA.5 It is now widely
accepted that OA is a disease that affects all joint tissues.
Currently, magnetic resonance imaging (MRI) is the preferred
modality to assess early OA.6 A comprehensive knee MRI
examination includes only the knee joint, requires longer
acquisition times, and fails to assess bone metabolism.7
Sodium fluoride (Na18F) positron emission tomography
(PET)/computed tomography (CT) provides an imaging alter-
native that detects molecular and cellular changes present in
bone before morphological changes appear.8-17 Because
changes in bone metabolism are present long before morpho-
logical signs, Na18F can sooner identify and characterize early
OA, allowing for quicker treatment and closer monitoring of
disease progression.9,18 There is evidence in the literature that
Na18F PET was able to identify bone remodeling in the hip
joint before morphological signs appeared on MRI.9 More-
over, Na18F was able to detect metabolic abnormalities in
subchondral bone in the knee that appeared normal on MRI.19
Na18F as a bone metabolic tracer is currently primarily used
for assessing skeletal metastasis in oncologic diagnosis and
recently in cardiovascular calcifications. It has great potential
for molecular musculoskeletal imaging, including OA and
osteoporosis.8-18,20-25
Our group has used this canine model of knee PTOA and
assessed early OA changes using 18F-fluoro-D-glucose
(F-FDG) PET.26 Similar to coronary artery imaging, OA
should include both assessment of inflammation (18F-FDG)
and calcium metabolism (Na18F).8 Thus, 18F-FDG and Na18F
PET comprise excellent noninvasive in vivo molecular ima-
ging biomarkers to evaluate the early pathophysiology of
PTOA.8 The uptake of Na18F in the bone is determined by
vascular perfusion and bone surface accessibility for ion
exchange, indirectly reflecting bone formation and bone
resorption.12 The advantages of Na18F PET/CT over conven-
tional nuclear medicine techniques, such as Technetium 99m-
methyl diphosphonate, to assess bone metabolism include
higher sensitivity, superior resolution images, improved target
to background ratio, and faster scan times.15
Current interest in the use of cross-sectional imaging tech-
niques, and their multimodal combination in clinical practice,
has led to combined hybrid modalities such as PET/CT and
PET/MRI, largely because it enables intraindividual compara-
tive studies. Combining functional and morphologic imaging
for patients with OA have been lacking, and further studies are
needed.
Surgically induced PTOA in the canine model has proved to
be an excellent spontaneous model of disease. Furthermore, the
canine knee (stifle) anatomy is markedly similar to that of
humans.27-35 The rationale for using this model is that ACL
injury causes joint destabilization which subsequently leads to
PTOA. The model imitates the degradation of the joint
structures after ACL rupture. The noninvasive anterior cruciate
ligament transection (ACLT) canine model thus, constitutes a
great fit for translational multimodal imaging utilizing human
clinical MRI and PET scans.
Understanding how molecular imaging biomarkers are
linked with early OA progression is critical to the development
of targeted therapies, reducing the incidence and magnitude of
premature joint disease and disability. Therefore, in this study,
we assess the feasibility of a novel approach of Na18F PET/CT
coregistered with MRI to detect and quantify pathological bone
changes in this canine model of PTOA.
The aim of this study was to serially assess bone metabolism
in a noninvasive in vivo canine model of knee PTOA. As such,
we hypothesize that injury-induced inflammation induces bone
molecular changes in the knee that undergoes ACLT compared
to the contralateral knee. We further hypothesize that Na18F
uptake will be increased in the contralateral knee after injury-
induced trauma.
Materials and Methods
Study Design
Procedures were approved by the local University Institutional
Laboratory Animal Care and Use Committee. Five (n ¼ 5)
healthy, skeletally mature male beagles (age 5 years; weighing
10-13 kg) were used. All dogs were without any clinical and
radiological signs of orthopedic disorders. The dogs were indi-
vidually housed in indoor pens and were fed a standard diet
with water ad libitum.
Induction of OA
Dogs underwent general anesthesia induced by acepromazine
(Vedco; Saint Joseph, Missouri; intravenously (IV), 0.2 mg/kg),
ketamine (Ketaset; Fort Dodge Animal Health, Overland Park,
Kansas; IV, 6 mg/kg), and diazepam (Valium; Roche, Madison,
Wisconsin; IV, 0.35 mg/kg) and maintained by isoflurane (Iso-
Flo; Abbott, Parsippany, New Jersey; infusion, 2%-4%). Bilat-
eral knee arthroscopy using standard portals was performed to
evaluate intra-articular structures. Using randomization, one
knee had the anterior cruciate ligament transected, while the
ACL in the contralateral knee was left intact (uninjured). The
contralateral knee arthroscopy was performed to evaluate knee
structures and to balance possible effects of the arthroscopy
procedure itself, such as swelling or effusion, on postoperative
knee imaging.
Positron Emission Tomography/Computed Tomography
Imaging
Prior to, 3, and 12 weeks post-ACLT, under general anesthesia,
the dogs underwent Na18F PET/CT. The patients were placed
in supine position in a custom-made table with both knees
extended into the designed custom-made foam knee coil, in
order to mimic the same position as in the MRI knee coil and
to facilitate MRI coregistration. The table and foam knee coil
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positioning device together helped to consistently coregister
both modalities. Sodium fluoride of 111 MBq (3 mCi) was
injected in the cephalic vein via IV catheter. List mode time-
of-flight raw data were acquired on the Gemini 64 TF with
Astonish (Philips, Cleveland, Ohio) PET/CT system. Four
millimeter (mm) isotropic voxel data sets (144  144 matrix
size using a 576-mm field of view [FOV]) and 90 seconds/bed
were reconstructed using the system default reconstruction
parameters (3 iterations and 33 subsets). Computed tomogra-
phy was acquired using the multislice helical system at 120
KVp, 163 mAs, and reconstructed with a 4-mm slice thickness,
512  512 matrix size, and 600-mm FOV for attenuation cor-
rection and coregistration. Whole-body static PET was
acquired 30 minutes after 18F-NaF administration for a dura-
tion of 20 minutes (Figures 1–3).
Magnetic Resonance Imaging
Prior to, 3, and 12 weeks post-ACLT, under general anesthesia,
the canines underwent MRI. A 3-T MRI human whole-body
system (Achieva, Philips Healthcare, Cleveland, Ohio) equipped
with an 8-channel knee coil was used. Dogswere placed in supine
position, with both knees extended in the knee coil. A custom-
made table was used to ensure the same position in both the MRI
and the PET/CT. A clinical standard axial proton density (PD)
turbo spin-echo (TSE) Spectral Presaturation with Inversion
Recovery (SPIR) (Echo time [TE] ¼ 15 ms, Repetition time
[TR] ¼ 2.1 seconds, flip angle ¼ 90, slice thickness ¼ 2 mm,
FOV¼ 115mm, acquisitionmatrix 144 124, voxel size: FH¼
0.56 mm, and AP¼ 0.7 mm) and a sagittal PD TSE fat saturated
(TE¼ 45ms, TR¼ 2.2 seconds, flip angle¼ 90, slice thickness
¼ 2 mm, and FOV ¼ 88 mm) were acquired (Figure 1).
Analysis of PET/MRI
The PET/CT and MRI scans were performed in the same week
for each time point and were coregistered using the Philips
IntelliSpace Portal (version 6) workstation that uses an inter-
polation methodology to adjust for different matrix sizes.
Three-dimensional (3D) regions of interest (ROIs) were traced
Figure 1. Representative knee MRI (proton density turbo spin-echo SPIR), Na18F PET, and Na18F PET/MRI coregistered (from left to right) axial
views of the knee femoral condyles at baseline, 3 weeks, and 12 weeks post-ACLT (top to bottom), showing detailed knee morphology in the
co-registered modalities. Showing Na18F background uptake at baseline, compared to higher uptake at 3 weeks, and significantly higher uptake at
12 weeks post-ACLT (bottom row). This elevated radioisotope uptake represented bone metabolism enhancement, caused by the injury-
induced trauma. 3D regions of interest (6 mm) were manually traced over the lateral femoral condyle (yellow circles). ACLT indicates anterior
cruciate ligament transection; 3D, three dimensional; MRI, magnetic resonance imaging; Na18F, sodium fluoride; PD, proton density; PET,
positron emission tomography; SPIR, Spectral Presaturation with Inversion Recovery; TSE, turbo spin-echo.
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manually by an experienced veterinarian (MIM) to determine
the SUVmax in a consistent way. The 3D spheres of 6-mm
diameter were traced for the lateral femoral condyle, medial
femoral condyle, lateral tibia, and medial tibia (Figure 1).
Statistical Analyses
The linear mixed-effect model was used to study the associa-
tion between the type of treatment (ACLT and uninjured) and
the Na18F SUVmax at each ROI and time point of the PET
images as well as the association of the Na18F SUVmax among
the time points at each ROI for ACLT and uninjured, respec-
tively. To determine the correlation within and between dogs,
the Holm-Bonferroni method was used to adjust for multipli-
city. P values <.05 were considered statistically significant.
Statistical analysis was performed using SAS version 9.3 (SAS
Institute, Cary, North Carolina).
Results
Both in vivo imaging modalities, Na18F PET/CT and MRI,
were successfully completed prior to, 3, and 12 weeks post-
ACLT for all dogs and all image sets were successfully core-
gistered (Figure 1).
At baseline, before the induced injury was created, the knees
had no pathological detectable uptake. Every 3D ROI assessed
at baseline, in both knees, showed no Na18F uptake above
background, quantitatively verified using SUVmax (Figures
1–4; Table 1).
At 12 weeks post-ACLT, all 3D ROIs assessed in the ACLT
knees compared to the contralateral uninjured knees presented
with significantly higher Na18F SUVmax uptake, including lat-
eral and medial femur and tibia. The greatest uptake was
detected at 12 weeks in the medial tibia region from the ACLT
knees (Na18F SUVmax ¼ 8.57+ 0.66; mean+ standard error;
Figures 3 and 4; Table 1).
At 3 weeks post-ACLT, the femur 3D ROIs in the ACLT
knees, both lateral and femoral condyles, showed significantly
higher Na18F SUVmax compared to the uninjured knees. The
medial tibia followed a similar pattern, although it was not
significantly different (Figures 3 and 4).
At 12 weeks, knees that underwent ACLT had significantly
higher Na18F uptake in every 3D ROI compared to the baseline.
Interestingly, the medial femoral condyle ROIs also presented
with increased significantly higher uptake at 3 and 12 weeks
compared to the baseline (Figure 4; Table 2).
At 3 and/or 12 weeks post-ACLT, all dogs presented a visi-
ble, localized higher Na18F uptake in the medial tibia of the
ACLT knee (Figures 2 and 3).
Surprisingly, the Na18F uptake was elevated in all assessed
regions in the uninjured, contralateral knees at 12 weeks com-
pared to the baseline. Although the substantial uptake was
Figure 2. Representative Na18F PET and Na18F PET/CT views of a knee 12 weeks post-ACLT, showing higher Na18F uptake of the 3D ROI in
the medial tibia (yellow and black circles). This uptake represents bone metabolism changes and may be indicative of osteophyte formation.
ACLT indicates anterior cruciate ligament transection; 3D, three dimensional; Na18F, sodium fluoride; PET/CT, positron emission tomography/
computed tomography; ROI, region of interest.
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visually observed, it was not statistically significant (Figures 3
and 4).
When assessing the static whole-body Na18F PET at12
weeks after injury-induced trauma in the ACLT knees, the
ipsilateral distal tibia, tarsal joints, and metatarsal bone showed
dramatic Na18F uptake. Furthermore, the contralateral unin-
jured knee and distal joints also presented consistently with
elevated Na18F uptake. Additionally, in the front limbs, carpal
joints and some metacarpal joints exhibited elevated tracer
uptake (Figure 3).
Discussion
This study demonstrates the feasibility of Na18F PET/CT cor-
egistered with MRI as a novel diagnostic tool to quantify patho-
physiological bone metabolism in an in vivo canine model of
PTOA in the knee.
The incorporation of Na18F into the bone matrix results in
site-specific uptake in the knee joint, which enables not only
uptake visualization but also a quantitative regional measure-
ment (SUVmax) of pathological bone metabolism in a preclini-
cal model of PTOA.
At baseline, prior to ACLT, no Na18F uptake was detectable
in the healthy canine knees. This finding is consistent with a
similar arthritis study in a murine model.13 Our observation
differs from the murine study regarding the time point at which
the increased uptake and increased bone metabolism was
noted. In the murine model, the uptake decreased at 5 weeks,
whereas in our canine model, the uptake increased exponen-
tially, reaching highest uptake at 12 weeks.
All the regions of interest from the ACLT knees had signif-
icantly higher Na18F uptake compared to the uninjured knees at
12 weeks. This result may be related to the increased rate of
remodeling, which has been shown in an ACLT canine model
of OA, where thinning of the subchondral plate occurs.36,37 The
increased incorporation of Na18F into the bone matrix was
greater at 12 weeks than 3 weeks postinjury. This finding is
consistent with current studies in OA bone pathogenesis, where
OA subchondral bone remodeling is biphasic. In the early
stage, there is increased bone remodeling, and as the OA pro-
gresses, the remodeling decreases while bone formation
increases.38
Whole-body static Na18F PET allowed us to detect bone
metabolic changes in the whole body. We expected to see bone
metabolic changes with minor tracer uptake in the contralateral
uninjured knees due to the instability created by the ACL trans-
ection. We also observed 18F-FDG uptake in our previous
study, presenting a different radiotracer uptake pattern, show-
ing higher 18F-FDG uptake 3 weeks post-ACLT, in contrast to
the higher Na18F uptake at 12 weeks presented in this study.
These findings are consistent with the concept that 18F-FDG is
trapped in cells after phosphorylation, presenting inflammation
due to increased glucose metabolism.26 A different pattern is
showed with Na18F, which accumulates in the bone when bone
remodeling is increased. Both molecular imaging biomarkers
complement each other to provide a deeper insight into early
knee PTOA pathogenesis.
The higher Na18F uptake observed in the medial tibia of the
ACLT knees at 3 weeks (4 dogs) and 12 weeks (5 dogs) may be
indicative of increased bone perfusion and highly significant
bone formation (osteophytes).
Surprisingly, several bones and joints presented higher
uptake, including the ipsilateral distal tibia, tarsal joint, and
metatarsal bone, and, to a lesser extent, the contralateral bones
and joints. Moreover, carpal joints and some metacarpal joints
in the front limbs exhibited elevated tracer uptake. These find-
ings may reveal a systemic effect created by transecting the
ACL, rather than altered gait mechanics due to joint instability.
Arthroscopic surgery was chosen to produce joint injury
minimizing the profound effects of arthrotomy, which may
lead to substantial synovitis, hemorrhage, joint capsular fibro-
sis, and associated pain and dysfunction. The canine model is
one of the most common studied species with respect to spon-
taneous models of OA due to the knee similarity to humans.28
It is important to mention some limitations of this study. The
contralateral knee joint was used as the uninjured comparison,
instead of using nonoperated control dogs. Using the uninjured
contralateral knee helped to minimize interanimal variation.
Figure 3. Representative whole-body static Na18F PET at baseline, 3
weeks, and 12 weeks post-ACLT. Red circles show the exponential
Na18F uptake across time points in the knee that underwent ACLT,
compared to the contralateral uninjured knee. At 12 weeks, the
ipsilateral distal tibia, tarsal joints, and metatarsal bone (dark blue
arrow) showed dramatic Na18F uptake. Furthermore, the contralat-
eral uninjured knee and distal joints (dark blue arrows) also had ele-
vated Na18F uptake. Additionally, the front limbs, carpal joints, and
some metacarpal joints exhibited elevated tracer uptake (light blue
arrows). ACLT indicates anterior cruciate ligament transection;
Na18F, sodium fluoride; PET, positron emission tomography.
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The study finalized 12 weeks post-ACLT. Longer studies will
help provide greater longitudinal data in early PTOA. The
purpose of coregistering MRI to Na18F PET/CT in this study
was to be able to compare both molecular imaging biomarker
studies. Magnetic resonance imaging analysis is not presented
in this report to focus on Na18F PET. Magnetic resonance
imaging was only used for localizing purposes and to keep
consistency when compared to previous studies done with the
Figure 4. ROI Na18F SUVmax from the ACLT and uninjured knees at baseline, 3 weeks, and 12 weeks. Data were expressed as mean+ SEM.
Different letters comparing ACLT ROIs across time (a, b, and c) differ significantly (P < .05). Asterisks (*) showed significant difference between
ACLT and uninjured knees. ACLT indicates anterior cruciate ligament transection; Na18F, sodium fluoride; ROI, region of interest; SEM,
standard error of the mean; SUVmax, maximum standardized uptake value.
Table 1. Na18F Maximum Standardized Uptake Values (SUVmax) of
3D Regions of Interest (ROIs) in the ACLT and Uninjured Knee at
Baseline, 3 Weeks, and 12 Weeks Post-ACLT.
Assessed
ROI Timeline
ACLT Na18F
SUVmax
(Mean+ SE)
Uninjured
Na18F SUVmax
(Mean + SE)
Linear Mixed
Model P Value
Lateral
femur
Baseline 1.16+ 0.32 1.15 + 0.32 .93
3 weeks 2.10+ 0.51 0.82 + 0.13 .03a
12 weeks 6.01+ 1.14 2.11 + 0.25 .01a
Medial
femur
Baseline 1.04+ 0.24 1.08 + 0.26 .60
3 weeks 2.29+ 0.48 0.73 + 0.08 .02a
12 weeks 5.91+ 1.11 1.55 + 0.25 .01a
Lateral
tibia
Baseline 1.37+ 0.34 1.42 + 0.30 1.00
3 weeks 2.72+ 1.46 0.84 + 0.22 .34
12 weeks 5.55+ 0.87 2.24 + 0.41 .001a
Medial
tibia
Baseline 1.20+ 0.26 1.39 + 0.30 .09
3 weeks 4.50+ 2.54 0.86 + 0.29 .14
12 weeks 8.57+ 0.66 1.91 + 0.32 <.001a
Abbreviations: ACLT, anterior cruciate ligament transection; 3D, three dimen-
sional; Na18F, sodium fluoride; SE, standard error.
aP < .05 considered significant.
Table 2. Na18F Maximum Standardized Uptake Values (SUVmax) of
3D Regions of Interest (ROIs) in the ACLT Knee at Baseline (BL), 3
Weeks, and 12 Weeks Post-ACLT, and Multiple Comparisons P Val-
ues Using Holm-Bonferroni.
Assessed
ROI Timeline
ACLT Na18F SUVmax
(Mean+ SE)
Holm-Bonferroni
P Value
Lateral
femur
3 weeks vs BL 0.94+ 0.57 .12
12 weeks vs BL 4.85+ 1.39 .01a
12 vs 3 weeks 3.91+ 1.45 .04a
Medial
femur
3 weeks vs BL 1.25+ 0.53 .04a
12 weeks vs BL 4.87+ 1.31 .01a
12 vs 3 weeks 3.62+ 1.35 .04a
Lateral
tibia
3 weeks vs BL 1.34+ 1.23 .59
12 weeks vs BL 4.17+ 1.15 .01a
12 vs 3 weeks 2.83+ 1.88 .31
Medial
tibia
3 weeks vs BL 3.30+ 2.39 .39
12 weeks vs BL 7.36+ 0.77 <.001a
12 vs 3 weeks 4.06+ 2.58 .28
Abbreviations: ACLT, anterior cruciate ligament transection; 3D, three dimen-
sional; Na18F, sodium fluoride; SE, standard error.
aP < .05 considered significant.
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same protocol. Histopathology was beyond the scope of this
article; thus, we cannot comment on the correlation between
higher uptake and bone pathology. Alternatively, we described
the abnormal bone changes. Further studies are needed with a
larger dog population to elucidate the different calcium meta-
bolic changes that we observed in the knees, additional bones,
and joints. Future studies will benefit from supplemental blood
biodistribution analyses. Furthermore, Na18F dose reduction
and reconstruction optimization should be examined in future
studies to minimize radiation exposure levels to as low as rea-
sonably achievable (ALARA).
We demonstrate the potential of Na18F PET/CT coregis-
tered with MRI to monitor serially and to quantify pathological
bone changes in this canine model of knee PTOA. Jointly, with
our previous 18F-FDG observations in the same canine model,
we present a noninvasive multimodal imaging methodology to
investigate the pathophysiology of OA through molecular ima-
ging biomarkers (Na18F and 18F-FDG), where bone changes
and inflammation are the major parameters used to assess early
PTOA. This preclinical model may provide new insights into
PTOA pathogenesis and lead to new OA targets than could be
translated to young adult patients to treat OA progression.
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